Tags

Type your tag names separated by a space and hit enter

[Development of glipizide push-pull osmotic pump controlled release tablets by using expert system and artificial neural network].
Yao Xue Xue Bao. 2012 Dec; 47(12):1687-95.YX

Abstract

The purpose of this study is to develop glipizide push-pull osmotic pump (PPOP) tablets by using a formulation design expert system and an artificial neural network (ANN). Firstly, the expert system for the formulation design of osmotic pump of poor water-soluble drug was employed to design the formulation of glipizide PPOP, taking the dissolution test results of Glucotrol XL as the goal. Then glipizide PPOP was prepared according to the designed formulations and the in vitro dissolution was carried out. And in vivo evaluation was carried out between the samples which were similar to Glucotrol XL and the Glucotrol XL in Beagle dogs. The range of the factors of formulation and procedure, which could influence the drug release, was optimized using artificial neural network. Finally, the design space was found. It was found that the target formulation which was similar to Glucotrol XL in dissolution test could be obtained in a short period by using the expert system. The samples which were similar to Glucotrol XL were bio-equivalent to the Glucotrol XL in Beagle dogs. The design space of the key parameter coating weight gain was 9.5%-12.0%. It could be concluded that a well controlled product of glipizide PPOP was developed since the dissolution test standard of our product was more strict than that of Glucotrol XL.

Authors+Show Affiliations

Zhang ZH
CSPC 1. Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., LTD, China.
Wang Y
No affiliation info available
Wu WF
No affiliation info available
Zhao X
No affiliation info available
Sun XC
No affiliation info available
Wang HQ
No affiliation info available

MeSH

AnimalsArea Under CurveDelayed-Action PreparationsDogsDrug CompoundingDrug Delivery SystemsDrug DesignExpert SystemsFemaleGlipizideHypoglycemic AgentsMaleNeural Networks, ComputerOsmosisPolyethylene GlycolsRandom AllocationSodium ChlorideSolubilityTablets

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

chi

PubMed ID

23460977

Citation

Zhang, Zhi-Hong, et al. "[Development of Glipizide Push-pull Osmotic Pump Controlled Release Tablets By Using Expert System and Artificial Neural Network]." Yao Xue Xue Bao = Acta Pharmaceutica Sinica, vol. 47, no. 12, 2012, pp. 1687-95.
Zhang ZH, Wang Y, Wu WF, et al. [Development of glipizide push-pull osmotic pump controlled release tablets by using expert system and artificial neural network]. Yao Xue Xue Bao. 2012;47(12):1687-95.
Zhang, Z. H., Wang, Y., Wu, W. F., Zhao, X., Sun, X. C., & Wang, H. Q. (2012). [Development of glipizide push-pull osmotic pump controlled release tablets by using expert system and artificial neural network]. Yao Xue Xue Bao = Acta Pharmaceutica Sinica, 47(12), 1687-95.
Zhang ZH, et al. [Development of Glipizide Push-pull Osmotic Pump Controlled Release Tablets By Using Expert System and Artificial Neural Network]. Yao Xue Xue Bao. 2012;47(12):1687-95. PubMed PMID: 23460977.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Development of glipizide push-pull osmotic pump controlled release tablets by using expert system and artificial neural network]. AU - Zhang,Zhi-Hong, AU - Wang,Yue, AU - Wu,Wen-Fang, AU - Zhao,Xi, AU - Sun,Xiao-Cui, AU - Wang,Huan-Qing, PY - 2013/3/6/entrez PY - 2013/3/6/pubmed PY - 2013/12/24/medline SP - 1687 EP - 95 JF - Yao xue xue bao = Acta pharmaceutica Sinica JO - Yao Xue Xue Bao VL - 47 IS - 12 N2 - The purpose of this study is to develop glipizide push-pull osmotic pump (PPOP) tablets by using a formulation design expert system and an artificial neural network (ANN). Firstly, the expert system for the formulation design of osmotic pump of poor water-soluble drug was employed to design the formulation of glipizide PPOP, taking the dissolution test results of Glucotrol XL as the goal. Then glipizide PPOP was prepared according to the designed formulations and the in vitro dissolution was carried out. And in vivo evaluation was carried out between the samples which were similar to Glucotrol XL and the Glucotrol XL in Beagle dogs. The range of the factors of formulation and procedure, which could influence the drug release, was optimized using artificial neural network. Finally, the design space was found. It was found that the target formulation which was similar to Glucotrol XL in dissolution test could be obtained in a short period by using the expert system. The samples which were similar to Glucotrol XL were bio-equivalent to the Glucotrol XL in Beagle dogs. The design space of the key parameter coating weight gain was 9.5%-12.0%. It could be concluded that a well controlled product of glipizide PPOP was developed since the dissolution test standard of our product was more strict than that of Glucotrol XL. SN - 0513-4870 UR - https://www.unboundmedicine.com/medline/citation/23460977/[Development_of_glipizide_push_pull_osmotic_pump_controlled_release_tablets_by_using_expert_system_and_artificial_neural_network]_ L2 - https://medlineplus.gov/diabetesmedicines.html DB - PRIME DP - Unbound Medicine ER -